Prevalence and Clinical Significance of Hepatitis C Virus Infection in Thai Patients with Thalassemia

International Journal of Hematology

Volumn 78, Issue 4, 2003, Pages 374-378

  Wanachiwanawin, Wanchai ^a,b   Luengrojanakul, Pairoj ^a   Sirangkapracha, Pornpan ^b   Leowattana, Wattana ^a   Fucharoen, Suthat ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Hepatitis C; Iron overload; Liver function; Thalassemia

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FERRITIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; SERUM ALBUMIN; TRANSFERRIN;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; ENZYME IMMUNOASSAY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; IRON OVERLOAD; IRON STORAGE; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SOUTHEAST ASIA; SOUTHERN EUROPE; THAILAND; THALASSEMIA; THALASSEMIA MAJOR;

EID: 0346850007     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983565     Document Type: Article

References (24)

1. Issaragrisil S, Wanachiwanawin W, Bhuripanyo K, Benjasuratwong Y, Piankijagum A, Wasi P. Infection in thalassemia: a retrospective study of 1,018 patients with β-thalassemia/Hb E. Birth Defects Orig Artic Ser. 1988;23:505-511.
2. Wanachiwanawin W. Infections in E-beta thalassemia. J Pediatr Hematol Oncol. 2000;22:581-587.
3. Fucharoen S, Piankijagum A, Wasi P. Deaths in β-thalassemia/Hb E patients secondary to infections. Birth Defects Orig Artic Ser. 1988; 23:495-500.
4. Alter HJ, Parcell RH, Shih JW, et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med. 1989;321: 1494-1500.
5. Sarbah SA, Younossi ZM. Hepatitis C: an update on the silent epidemic. J Clin Gastroenterol. 2000;30:125-143.
6. Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis C virus in multiply transfused patients with thalassaemia major. J Clin Pathol. 1990;43:638-640.
7. Erer B, Angelucci E, Lucarelli G, et al. Hepatitis C virus infection in thalassemia patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant. 1994;14:369-372.
8. Lai ME, De Virgilis S, Argiolu F, et al. Evaluation of antibodies to hepatitis C virus in long-term prospective study of posttransfusion hepatitis among thalassemic children: comparison between first-and second-generation assay. J Pediatr Gastroenterol Nutr. 1993;16: 458-464.
9. Alter HJ. To C or not to C: these are the questions. Blood. 1995;85: 1681-1695.
10. Luengrojanakul P, Vareesangthip K, Chainuvatti T, et al. Hepatic C virus infection in patients with chronic liver disease or chronic renal failure and blood donors in Thailand. J Med Virol. 1994;44: 287-292.
11. Nagayama R, Miyake K, Tsuda F, Okamoto H. IgM antibody to a hepatitis C virus core peptide (CP 14) for monitoring activity of liver disease in patients with acute or chronic hepatitis C. J Med Virol. 1994;42:311-317.
12. Okamoto H, Tsuda F, Machida A, et al. Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology. 1992;15:180-186.
13. Iizuka H, Ohmura K, Ishijima A, et al. Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBs Ag. Vox Sang. 1992;63:107-111.
14. International Committee for Standardization in Haematology (ICSH). The measurement of total and unsaturated iron-binding capacity in serum. Br J Haematol. 1978;38:281-287.
15. International Committee for Standardization in Haematology (ICSH). Recommendation for measurement of serum iron in human blood. Br J Haematol. 1978;38:291-294.
16. Cook JD, Dallman PR, Bothwell TH, et al. Serum ferritin: measurement of iron status. A report of the International Nutritional Anemia Consultative Group (INACG). Kansas, USA: International Nutritional Anemia Consultative Group (INACG); 1985: 35-54.
17. Laosombat V, Pornpatkul M, Wongchanchailert M, Worachai K, Wiriyasatienku A. The prevalence of hepatitis C virus antibodies in thalassemic patients in the south of Thailand. Southeast Asian J Trop Med Public Health. 1997;28:149-153.
18. Poovorawan Y, Pongpunlert W, Chumdermpadetsuk S, Sakulramrung R, Israsena S. The prevalence of hepatitis C virus antibodies among high risk groups in Thailand. Southeast Asian J Trop Med Public Health. 1991;22:133-134.
19. Williams TN, Wonke B, Donohue SM. A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemia and their parents. Indian Pediatr. 1992;29:1119-1124.
20. Khalifa AS, Mitchell BS, Watts DM, et al. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. Am J Trop Med Hyg. 1993;49:316-321.
21. Bejachandra S, Chongholwatana V, Panchavinnin W, et al. Serological infections disease markers in blood donated at Siriraj Hospital. Siriraj Hosp Gaz. 1998;50:16-27.
22. Borzini P, Cazzaniga G, Vecchi L. Prevalence of anti-hepatitis C virus seroconversion in polytransfused thalassemic patients. Vox Sang. 1991;60:188.
23. Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Southeast Asian J Top Med Public Health. 1998;29: 792-794.
24. Wasi P. Haemoglobinopathies including thalassaemia, part 1: tropical Asia. Clin Haematol. 1981;10:707-729.